Pamorelin (Triptorelin)

Triptorelin, the active ingredient in Pamorelin, is a synthetic gonadotropin-releasing hormone (GnRH) agonist presented as a sterile powder for solution for injection use. It is employed in the management of hormone‑dependent conditions such as prostate cancer, endometriosis and assisted reproduction protocols.

GNH USA supplies Pamorelin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Triptorelin acts on the gonadotropin‑releasing hormone pathway and is indicated for several hormone‑dependent conditions. - Prostate cancer: provides androgen suppression to slow tumor progression. - Endometriosis: reduces pelvic pain by suppressing estrogen production. - Assisted reproduction: controls ovarian stimulation timing during in‑vitro fertilisation cycles.

Adverse reactions to Triptorelin may vary in frequency and severity.

Common Side Effects: - Hot flashes: transient warmth and sweating. - Injection site pain: mild to moderate discomfort at the injection site. - Headache: occasional mild to moderate headache. - Nausea: occasional feeling of queasiness. - Fatigue: general tiredness or lack of energy. - Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, myocardial infarction or stroke. - Severe allergic reaction: anaphylaxis, rash, or angioedema. - Bone loss: osteopenia or osteoporosis with long‑term use. - Hormonal crisis: adrenal insufficiency or severe hormonal imbalance. - Liver dysfunction: elevated transaminases or hepatitis. - Pituitary apoplexy: sudden hemorrhage into the pituitary gland.

When using Triptorelin, careful assessment and monitoring are recommended. - Cardiovascular assessment: evaluate history of hypertension or heart disease. - Bone health monitoring: assess bone mineral density for long‑term therapy. - Hormonal status: monitor testosterone or estradiol levels during treatment. - Allergic reactions: watch for signs of hypersensitivity at each administration. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Triptorelin may interact with several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk during injection. - Hormone replacement therapy: can blunt intended hormonal effects.

Moderate Interactions (Monitor Closely): - Corticosteroids: may exacerbate bone loss when combined long‑term. - Antidepressants (SSRIs): potential for additive mood changes. - Antihypertensive agents: blood pressure may fluctuate during hormonal suppression. - Antiepileptic drugs: may alter hormone metabolism, requiring dose adjustments.